Jury In Repatha Patent Case Ruled In Favor Of Amgen, Against Regeneron And Sanofi

By: via Benzinga
Amgen, Inc. (NASDAQ: AMGN) has won a patent suit against Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and its partner Sanofi SA (ADR) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.